Extension Treatment Using EryDex System in Patients With AT Who Participated in the ATTeST-IEDAT-02-2015 Study (OLE-IEDAT)
Open-label, Long-term, Extension Treatment Using Intra-Erythrocyte Dexamethasone Sodium Phosphate (EryDex System) in Patients With Ataxia Telangiectasia Who Participated in the ATTeST-IEDAT-02-2015 Study
Sponsor: Quince Therapeutics S.p.A.
Terminated
terminated by sponsor
Other terminated trials from Quince Therapeutics S.p.A.
More terminations from Quince Therapeutics S.p.A.
Other Ataxia Telangiectasia trials with similar outcome
A PHASE3 clinical study on Ataxia Telangiectasia and Genetic Syndrome, this trial is terminated or withdrawn. The trial is conducted by Quince Therapeutics S.p.A. and has accumulated 11 data snapshots since 2018. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
11 versions recorded-
Nov 2024 — Present [monthly]
Terminated PHASE3
Status: Recruiting → Terminated
-
Sep 2024 — Nov 2024 [monthly]
Recruiting PHASE3
-
Jul 2024 — Sep 2024 [monthly]
Recruiting PHASE3
-
Jun 2024 — Jul 2024 [monthly]
Recruiting PHASE3
Status: Unknown Status → Recruiting
-
Sep 2023 — Jun 2024 [monthly]
Unknown Status PHASE3
Status: Recruiting → Unknown Status
▶ Show 6 earlier versions
-
Sep 2021 — Sep 2023 [monthly]
Recruiting PHASE3
-
Jan 2021 — Sep 2021 [monthly]
Recruiting PHASE3
-
Feb 2020 — Jan 2021 [monthly]
Recruiting PHASE3
-
Jun 2019 — Feb 2020 [monthly]
Recruiting PHASE3
-
Jan 2019 — Jun 2019 [monthly]
Recruiting PHASE3
Status: Not Yet Recruiting → Recruiting
-
Jul 2018 — Jan 2019 [monthly]
Not Yet Recruiting PHASE3
First recorded
Jun 2018
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Quince Therapeutics S.p.A.
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
Baltimore, United States , Bangalore, India , Chennai, India , Cincinnati, United States , Frankfurt, Germany , Houston, United States , Hyderabad, India , Leuven, Belgium , Los Angeles, United States , Madrid, Spain and 7 more locations